PER977 REVERSES LOW MOLECULAR WEIGHT HEPARIN IN ADDITION TO IIA AND XA NEW ORAL ANTICOAGULANTS

James Costin,Bryan Laulicht,Sasha H Bakhru,Solomon S Steiner

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2015）

引用 16|浏览11

暂无评分

摘要

There is no approved reversal agent or coagulation assay for low molecular weight heparin (LMWH). Given the significant number of bleeds on LMWH (reported as 12.7% or approximately 137,000 patients in the US annually), there is an urgent and unmet need for a reversal agent and rapid, point of care

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要